Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
Back Talk Articles
Pharma, heal thyself
Hensley Evans May 01, 2012
Improved patient outcomes must be a stated, and measured, goal of all players in the pharma industry
Closest to the customer wins
Ned Russell April 01, 2012
Agencies can embrace the need to change—or sit back and watch their value melt away
CES: Convergence continues
Joe Shields March 01, 2012
The desire to reduce the cost of delivering care has led to redefining 'point of care'
Docs, patients and pharma
Chad Latz February 01, 2012
Harnessing the power of digital and social media to maximize the doctor/patient relationship
Healthcare's tectonic shift
Lloyd Sheep January 01, 2012
Whether or not Obamacare survives in court, the cost-control squeeze is going to intensify
Making sense of safety data
December 01, 2011
A tidal wave of information is on the horizon. Processing, analyzing and drawing accurate conclusions from that information is healthcare's next major challenge.
Getting on the digital track
Liz Cermak November 01, 2011
Pharmaceutical companies have not moved nearly fast enough to keep up with their customers' digital preferences
What 1966 can still teach us
Ron Pantello October 01, 2011
More than enough has been written how change is affecting our industry today. Instead, let's look at what hasn't changed and why the things that have not changed remain important.
Potential of physician CRM
David Ormesher August 15, 2011
A lot of ink has been spilt on the decline of the blockbuster and the search for a new specialty-product commercial model. But less attention has been paid to how that changes marketing strategy.
Social health revolution
Laura Schoen July 15, 2011
While doctors and nurses remain the first choice for most people with health concerns, the internet is making a significant impact on patients' healthcare decisions.
« Previous
Next »
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Pfizer restructures comms, Kerins to depart this summer
Makers of pain pills, advocacy groups at center of Senate probe
Saatchi shop rebrands to sharpen specialty focus
Roche ends dalcetrapib trial, questions linger on CETP class
Docs trust ED drugs above all, go with their emotions when prescribing
RX-to-OTC proposal gets mixed reviews
Wolters Kluwer deals health analytics unit to private equity firm
Report: FDA hitting PDUFA targets, critics be darned
Nurses get their own app with Lippincott launch
Harvard urges faculty to ditch journals
Consumers getting comfortable with social media as a health resource
Massachusetts gift ban under attack (again)
Pharma Report 2012: Get Back in Shape
Enbrel reps risk layoff, as Pfizer calls early end to US selling
Have BMS and Gilead found the 'killer app' for hep. C?
Novo Nordisk plans US hiring spree as Q1 sales jump 10%
Pfizer, Crestor tops for global promotional spend in 2011
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Bydureon catching on among endos but low profits expected, Amylin says
Indian conglomerate buys Manhattan Research parent for $635m
Sales forces shrank in 2011, but not everywhere
National plan seeks Alzheimer's treatment by 2025
Coach vs. cancer in BMS-backed awareness effort
Wolters Kluwer deals health analytics unit to private equity firm
RX-to-OTC proposal gets mixed reviews
Siding with Lilly, appeals court overturns decision in rep overtime case
Humira on solid ground, analysts say, despite vote on Pfizer hopeful
Makers of pain pills, advocacy groups at center of Senate probe
Saatchi shop rebrands to sharpen specialty focus
Popular Topics
Acquisition
Adherence
Agency
App
Conflict Of Interest
Digital
Direct To Consumer (DTC)
Downsize
Education & Awareness
FDA
Law
Marketing Research
Media
Medical Journal
Mobile
Obesity
Oncology
Patients
Physicians
Rebranding
Regulatory
REMS
Reputation
Sales Force
Samples